Full-Time

Biotech Research Associate

Healthcare Equity Research

B. Riley Securities

B. Riley Securities

51-200 employees

Middle-market investment bank for M&A, financings

No salary listed

San Francisco, CA, USA + 2 more

More locations: Arlington County, Arlington, VA, USA | New York, NY, USA

In Person

Master's, PharmD, PhD, MD

Category
Biology & Biotech (1)
Required Skills
Bloomberg
Python
R
Excel/Numbers/Sheets
Financial Modeling

Get referred to B. Riley Securities

See people who can refer or advise you

Requirements
  • One to three years of experience in biotechnology or pharmaceuticals through equity research, investment banking, consulting, industry, or clinical/scientific roles, or an advanced scientific degree with demonstrated interest in public markets.
  • Ability to interpret clinical and scientific data and translate findings into investment implications.
  • Solid financial modeling and analytical skills with advanced Excel proficiency.
  • Strong written communication and attention to detail under deadline pressure.
  • Willingness to obtain the required FINRA licenses (SIE, Series 7, 63, 86/87) after hire.
  • Strong work ethic, intellectual curiosity, integrity, and a team-first attitude.
Responsibilities
  • Support biotech and pharmaceutical public equity coverage, including earnings, clinical data readouts, and medical conference events.
  • Conduct scientific, clinical, regulatory, and competitive due diligence and distill findings into investment implications.
  • Track catalysts across the coverage universe and communicate developments to the team in a timely manner.
  • Build and maintain financial models, including revenue builds, probability-adjusted forecasts, and comparable-company sheets.
  • Develop and maintain therapeutic class, disease area, and regulatory precedent databases.
  • Construct forecasts and sensitivity analyses supporting investment recommendations.
  • Draft research notes, flash updates, and companion sales materials requiring minimal editing before publication.
  • Communicate actionable ideas on morning and midday calls and respond to requests from the sales force and institutional clients.
  • Participate in management calls, key opinion leader discussions, investor conferences, and corporate access initiatives.
  • Obtain all FINRA licenses (SIE, Series 7, 63, 86/87) within the first six months.
  • Master financial modeling, accounting fundamentals, and the therapeutic areas under coverage.
  • Develop proprietary insight into coverage names and proactively identify timely product ideas.
  • Handle client requests independently when the analyst is unavailable.
  • Build complex models with accurate forecasting.
  • Manage several names under coverage with minimal supervision.
  • Develop and maintain corporate and key opinion leader relationships that secure valuable access.
  • Lead new coverage launches from initiation through publication.
Desired Qualifications
  • An advanced degree (Ph.D., M.D., Pharm.D., or Master's) in life sciences or a related field.
  • Prior sell-side equity research experience in healthcare or biotechnology.
  • Familiarity with FactSet, Bloomberg, AlphaSense, ClinicalTrials.gov, and scientific literature review.
  • Experience applying data analysis or coding in Python or R to clinical or financial datasets.
  • CFA designation or active candidacy.

FocalPoint Partners, part of B. Riley Financial, acts as a middle-market investment bank that advises on mergers and acquisitions, private placements of debt and equity, financial restructurings, and special-situation transactions. It provides advisory services and capital-raising support, helping client companies identify options, evaluate targets or partners, prepare and negotiate deals, and connect with lenders or investors across its offices. The firm differentiates itself by focusing on middle-market deals with a full range of services and a multinational office network, including a Shanghai presence that supports cross-border work. Its goal is to help middle-market clients achieve successful outcomes in complex financial transactions by guiding the capital-raising and advisory process from start to finish.

Company Size

51-200

Company Stage

N/A

Total Funding

$8.8M

Headquarters

Los Angeles, California

Founded

2002

Get referred to B. Riley Securities

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • January 2026 WhiteFiber notes and September 2025 OTG IPO show underwriting momentum.
  • April 2026 New York sales-trading hires strengthen distribution after the 2025 San Francisco expansion.
  • May 2026 leadership appointments signal aggressive rebuilding across capital markets and investment banking.

What critics are saying

  • BRC Group faces a $735 million Franchise Group fraud suit filed January 2026.
  • Franchise Group collapsed in 2024, exposing B. Riley's deal diligence and reputation.
  • If litigation and funding pressure intensify, B. Riley Securities loses client trust and talent.

What makes B. Riley Securities unique

  • B. Riley Securities combines middle-market banking, restructuring, and research-driven distribution nationwide.
  • May 2026 returnees Patrice McNicoll and Matt Feinberg deepen capital markets origination.
  • April 2025 TMT and healthcare hires broaden coverage across technology, media, healthcare.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Holidays

Paid Vacation

Paid Sick Leave

401(k) Retirement Plan

Profit Sharing

Company News

ABF Journal
Jun 11th, 2026
B. Riley Securities Acts as Sole Bookrunner for Gladstone Capital in $60MM Notes Offering

B. Riley Securities, a full-service investment bank, served as sole bookrunner to Gladstone Capital in the closing of its $60 million aggregate principal

PR Newswire
May 19th, 2026
B. Riley Securities appoints Patrice McNicoll and Matt Feinberg to executive leadership roles

B. Riley Securities has appointed Patrice McNicoll as Co-President and Head of Capital Markets and Matt Feinberg as Co-Head of Investment Banking. Both executives are returning to the firm after previously holding leadership positions there. McNicoll and Feinberg bring decades of dealmaking experience, having originated and executed billions of dollars in capital markets transactions including public equity and debt offerings, institutional private placements and strategic advisory mandates. During their previous tenures at B. Riley Securities, they led high-profile financings across infrastructure, healthcare, real estate, power and technology sectors. Most recently, both held leadership positions at Yorkville Securities, where McNicoll served as Co-CEO and Feinberg as Co-Head of Investment Banking. They will partner with Joe Nardini, Co-President and Head of Investment Banking, to accelerate growth.

PR Newswire
Apr 21st, 2026
B. Riley Securities adds two senior hires to New York institutional sales desk

B. Riley Securities has expanded its New York institutional sales and trading desk with two senior hires. Seamus O'Neill returns to the firm as senior sales trader, bringing over 30 years of experience in institutional equity and options markets, most recently from Outset Global. TJ Bealko joins the institutional equity sales team after nearly a decade at Bank of America and RBC Capital Markets. He brings extensive capital markets expertise and relationships within the hedge fund community. The additions strengthen B. Riley Securities' bi-coastal institutional presence following its 2025 San Francisco expansion. The investment bank aims to deepen client coverage and enhance distribution capabilities for its research-driven services across equity offerings, debt solutions, M&A advisory and corporate restructuring.

GlobeNewswire
Sep 29th, 2025
CISO Global Enters Into a $15 Million Convertible Preferred Equity Facility to Fund Expansion Initiatives

Scottsdale, AZ, Sept. 29, 2025 (GLOBE NEWSWIRE) -- CISO Global (NASDAQ: CISO) (“CISO” or the “Company”), a leading provider of AI-powered cybersecurity...

PR Newswire
Apr 15th, 2025
B. Riley Securities Strengthens Its Technology, Media And Telecommunications Team With Three Senior Hires

Matthew Doull Joins as Senior Managing Director in Investment Banking; within Equity Research, Drew Crum to Cover Media & Entertainment and Erik Suppiger to Cover Enterprise Software & SecurityLOS ANGELES, April 15, 2025 /PRNewswire/ -- B. Riley Securities Holdings, Inc. ("B. Riley Securities," "BRS" or the "Company"), a leading middle market investment bank, continues to strengthen its platform with key hires across its TMT investment banking and research practice.Matthew Doull joins as Senior Managing Director with over two decades of experience advising global internet, digital media and innovative technology companies. Prior to joining BRS, Matthew was a Managing Director at Wedbush Securities where he served as co-Head of Technology Investment Banking. Prior to that, he was Managing Director, Head of Internet and Digital Media and co-Head of Technology Investment Banking at BDA Partners